Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, TERADYNE, INC insiders sold a net $14.3M of stock across 150 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
11 earlier Form 4 trades (code P or S) here by this insider (1 buy, 10 sales), the last on Oct 15, 2026.
The trade is 3.2% of the 12,640 shares held after it.
2 other insiders sold within 30 days.
829 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director MATZ MARILYN sold about $140.0K of TER under a 10b5-1 plan on Oct 21, 2026; 2 other insiders sold within 30 days and 829 funds added in the latest 13F quarter.
10 earlier Form 4 trades (code P or S) here by this insider (1 buy, 9 sales), the last on Sep 17, 2026.
The trade is 6.1% of the 13,040 shares held after it.
2 other insiders sold within 30 days.
829 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director MATZ MARILYN sold about $273.0K of TER under a 10b5-1 plan on Oct 15, 2026; 2 other insiders sold within 30 days and 829 funds added in the latest 13F quarter.
21 earlier Form 4 trades (code P or S) here by this insider (21 sales), the last on Sep 15, 2026.
The trade is 3.8% of the 104,495 shares held after it.
2 other insiders sold within 30 days.
829 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO Smith Gregory Stephen sold about $1.4M of TER under a 10b5-1 plan on Oct 15, 2026; 2 other insiders sold within 30 days and 829 funds added in the latest 13F quarter.
32 earlier Form 4 trades (code P or S) here by this insider (32 sales), the last on Sep 1, 2026.
The trade is 2.7% of the 6,197 shares held after it.
2 other insiders sold within 30 days.
829 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director JOHNSON MERCEDES sold about $67.3K of TER under a 10b5-1 plan on Oct 1, 2026; 2 other insiders sold within 30 days and 829 funds added in the latest 13F quarter.
9 earlier Form 4 trades (code P or S) here by this insider (1 buy, 8 sales), the last on Sep 15, 2026.
The trade is 2.9% of the 13,840 shares held after it.
2 other insiders sold within 30 days.
829 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director MATZ MARILYN sold about $140.4K of TER under a 10b5-1 plan on Sep 17, 2026; 2 other insiders sold within 30 days and 829 funds added in the latest 13F quarter.
150 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
TER planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
MATZ MARILYN
Filed 2026-10-21
$140.0K
MATZ MARILYN
Filed 2026-10-15
$273.0K
Smith Gregory Stephen
Filed 2026-10-15
$1.4M
JOHNSON MERCEDES
Filed 2026-10-01
$67.3K
MATZ MARILYN
Filed 2026-09-17
$140.4K
TER mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
AMERICAN GROWTH FUND Series One
$4.2M position · as of 2026-07-31
18.9%
ARK Autonomous Technology & Robotics ETF
$123.3M position · as of 2026-07-31
6.6%
Fidelity Disruptive Automation ETF
$12.4M position · as of 2026-05-31
5.9%
Sofi Agentic AI ETF
$654.7K position · as of 2026-05-31
5.8%
Paradigm Select Fund
$16.3M position · as of 2026-06-30
5.7%
Themes Humanoid Robotics ETF
$3.4M position · as of 2026-06-30
5.4%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Gregory SSmith
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$11.8M
$17.1M
$2.9M
+89%
+147%
2022
$10.6M
-$16.4M
$2.7M
+30%
+61%
2021
$11.0M
$37.5M
$2.5M
+142%
+146%
2020
$10.4M
$38.7M
$2.2M
+77%
+58%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $14.3M sold by insiders over 180 days, 829 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $5.9M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$4.5B
four quarters, 2025-06-30 to 2026-06-28
Revenue, TTM TER
FY Dec 2025
$3.2B
FY Dec 2024
$2.8B
FY Dec 2023
$2.7B
FY Dec 2022
$3.2B
FY Dec 2021
$3.7B
Jun 2026
$1.3B
Mar 2026
$1.3B
Dec 2025
$1.1B
Sep 2025
$769.2M
Jun 2025
$651.8M
Mar 2025
$685.7M
Dec 2024
$752.9M
Sep 2024
$737.3M
At each fiscal year end
Single quarter
Net margin, TTM
+25.8%
net income over revenue, 2025-06-30 to 2026-06-28
Net margin, TTM TER
FY Dec 2025
+17.4%
FY Dec 2024
+19.2%
FY Dec 2023
+16.8%
FY Dec 2022
+22.7%
FY Dec 2021
+27.4%
Jun 2026
+28.2%
Mar 2026
+31.1%
Dec 2025
+23.7%
Sep 2025
+15.5%
Jun 2025
+12.0%
Mar 2025
+14.4%
Dec 2024
+19.4%
Sep 2024
+19.8%
At each fiscal year end
Single quarter
Free cash flow, TTM
$799.9M
operating cash flow minus capex, 2025-06-30 to 2026-06-28
Free cash flow, TTM TER
FY Dec 2025
$450.4M
FY Dec 2024
$474.1M
FY Dec 2023
$425.6M
FY Dec 2022
$414.7M
FY Dec 2021
$965.9M
Jun 2026
$378.4M
Mar 2026
$200.4M
Dec 2025
$218.8M
Sep 2025
$2.4M
Jun 2025
$131.7M
Mar 2025
$97.6M
Dec 2024
$225.2M
Sep 2024
$114.4M
At each fiscal year end
Single quarter
Debt to equity
0.00x
long-term 2022-12-31 (42 months older than the period end) plus current 2026-06-28; equity 2026-06-28
Debt to equity TER
FY Dec 2025
0.07x
FY Dec 2024
0.00x
FY Dec 2023
0.00x
FY Dec 2022
0.00x
FY Dec 2021
0.03x
Jun 2026
0.00x
Mar 2026
0.00x
Dec 2025
0.07x
Sep 2025
0.07x
Jun 2025
0.00x
Mar 2025
0.00x
Dec 2024
0.00x
Sep 2024
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt to cover
Cash flow to debt TER
FY Dec 2025
3.37x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
12.31x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
3.37x
Sep 2025
3.38x
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+36.7%
TTM net income over average of 2025-06-29 and 2026-06-28
Return on equity TER
FY Dec 2025
+19.7%
FY Dec 2024
+20.3%
FY Dec 2023
+18.0%
FY Dec 2022
+28.5%
FY Dec 2021
+42.5%
Jun 2026
+36.7%
Mar 2026
+28.7%
Dec 2025
+19.7%
Sep 2025
+15.8%
Jun 2025
+16.9%
Mar 2025
+21.6%
Dec 2024
+20.3%
Sep 2024
+19.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+26.5%
TTM net income over average of 2025-06-29 and 2026-06-28
Return on assets TER
FY Dec 2025
+14.0%
FY Dec 2024
+15.1%
FY Dec 2023
+12.8%
FY Dec 2022
+19.6%
FY Dec 2021
+27.2%
Jun 2026
+26.5%
Mar 2026
+21.0%
Dec 2025
+14.0%
Sep 2025
+11.5%
Jun 2025
+12.7%
Mar 2025
+16.2%
Dec 2024
+15.1%
Sep 2024
+14.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+41.8%
operating income after a 13.5% effective tax rate, over long-term 2022-12-31 (42 months older than the period end) plus current 2026-06-28 plus average of 2025-06-29 and 2026-06-28 minus cash
Return on invested capital TER
FY Dec 2025
+22.1%
FY Dec 2024
+26.6%
FY Dec 2023
+25.4%
FY Dec 2022
+46.6%
FY Dec 2021
+72.1%
Jun 2026
+41.8%
Mar 2026
+33.5%
Dec 2025
+22.1%
Sep 2025
+17.4%
Jun 2025
+19.7%
Mar 2025
+27.5%
Dec 2024
+26.6%
Sep 2024
+23.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+39.1%
operating income (EBIT proxy) over average of 2025-06-29 and 2026-06-28 minus current liabilities
Return on capital employed TER
FY Dec 2025
+21.1%
FY Dec 2024
+20.1%
FY Dec 2023
+18.0%
FY Dec 2022
+28.9%
FY Dec 2021
+40.3%
Jun 2026
+39.1%
Mar 2026
+30.9%
Dec 2025
+21.1%
Sep 2025
+16.6%
Jun 2025
+17.0%
Mar 2025
+21.5%
Dec 2024
+20.1%
Sep 2024
+19.1%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
42.45x
close 2026-10-26 over four quarters of diluted EPS, 2025-06-30 to 2026-06-28
P/E, trailing TER
FY Dec 2025
55.78x
FY Dec 2024
37.81x
FY Dec 2023
39.75x
FY Dec 2022
20.65x
FY Dec 2021
29.57x
Jun 2026
60.01x
Mar 2026
54.84x
Dec 2025
55.78x
Sep 2025
49.20x
Jun 2025
31.26x
Mar 2025
23.38x
Dec 2024
37.81x
Sep 2024
42.74x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$48.0B
market value at close 2026-10-26 on 2026-07-27 shares, plus long-term 2022-12-31 (42 months older than the period end) plus current 2026-06-28, minus cash 2026-06-28
Enterprise value TER
FY Dec 2025
$30.2B
FY Dec 2024
$20.0B
FY Dec 2023
$15.8B
FY Dec 2022
$12.8B
FY Dec 2021
$25.6B
Jun 2026
$68.0B
Mar 2026
$46.0B
Dec 2025
$30.2B
Sep 2025
$21.5B
Jun 2025
$14.2B
Mar 2025
$12.9B
Dec 2024
$20.0B
Sep 2024
$21.5B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+1.7%
TTM free cash flow over market value at close 2026-10-26
FCF yield TER
FY Dec 2025
+1.5%
FY Dec 2024
+2.3%
FY Dec 2023
+2.6%
FY Dec 2022
+3.0%
FY Dec 2021
+3.6%
Jun 2026
+1.2%
Mar 2026
+1.2%
Dec 2025
+1.5%
Sep 2025
+2.1%
Jun 2025
+3.9%
Mar 2025
+4.5%
Dec 2024
+2.3%
Sep 2024
+2.1%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.28x
P/E over trailing EPS growth of 152%: four quarters to 2026-06-28 against the four to 2025-06-29
PEG, trailing TER
FY Dec 2025
13.27x
FY Dec 2024
1.72x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
1.01x
Jun 2026
0.40x
Mar 2026
1.05x
Dec 2025
13.27x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
0.68x
Dec 2024
1.72x
Sep 2024
14.53x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
TER ranks highest on financial health (99th percentile) and profitability (97th), and lowest on insider conviction (10th), among Industrials peers.
Profitability
97
Inputs
Return on equity+36.7% · 94 pct, sector of 198
Return on assets+26.5% · 99 pct, sector of 224
Return on invested capital+41.8% · 97 pct, sector of 107
Return on capital employed+39.1% · 99 pct, sector of 195
Financial health
100
Inputs
Debt to equity0.00x · 100 pct, sector of 214
Cash flow to debtno debt to cover
Growth
38
Inputs
Revenue growth, YoY+13.1% · 74 pct, sector of 254
Backlog growth, YoY-86.0% · 1 pct, sector of 89
Insider conviction
10
Inputs
Net Form 4 buying (codes P and S), 180d-$10.6M · 20 pct, sector of 170
Insider buyers, 180d0 · 0 pct, sector of 172
Institutional and government
77
Inputs
Funds adding, latest quarter829 · 94 pct, sector of 201
Congress net buyers, 365d0 · 57 pct, sector of 43
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$1.3M · 80 pct, sector of 67
Risk and compliance
51
Inputs
Short interest, % of float+5.5% · 38 pct, sector of 269
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 191
New text in Risk Factors, latest 10-K+22.7% · 16 pct, sector of 197
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
TER filings, in plain words
Are Teradyne insiders buying or selling TER?
In the 180 days to 2026-10-27, Teradyne insiders were net sellers, a net $14.3M across purchases and sales reported on Form 4, by 5 sellers.
Have members of Congress traded TER?
Yes. In the year to 2026-10-27, 1 House member disclosed buying TER and 1 House member disclosed selling it; the latest on record is a sale by Lisa McClain dated 2025-10-31.
Are there planned insider sales of TER?
Yes. 11 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $5.9M of stock; the latest, by MATZ MARILYN, was filed 2026-10-21.
Read the full summary
In the 180 days to 2026-10-27, Teradyne insiders were net sellers of TER, a net $14.3M across purchases and sales reported on Form 4 by 5 sellers. 35% of the 23 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-27, 1 member of Congress disclosed buying TER and 1 member disclosed selling it; the latest on record is a sale by Lisa McClain dated 2025-10-31. Insiders filed 11 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $5.9M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.